CNS Pharmaceuticals

CNSPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.863 M

$5.38 +2.77%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$15.9M

Loss-making

Shares outstanding

811,449

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#444Ensysce BiosciencesENSC$7.99M
#445Moleculin BiotechMBRX$7.98M
#446CNS PharmaceuticalsCNSP$7.86M
#447Bolt BiotherapeuticsBOLT$7.78M
#448MetaViaMTVA$7.69M

Where these numbers come from

Share counts and financials for CNS Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.